| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 08/03/2010 | US7767669 inhibitors of phosphatidyl inositol (PI) 3-kinase, such as 4-(1H-indazol-5-ylamino)-6- (4-methoxy-3- methylphenyl)-2-morpholin- 4-ylpyrimidine-5-carboxylic acid, used for the treatment of breast cancer |
| 08/03/2010 | US7767667 Pesticidal heterocycles |
| 08/03/2010 | US7767666 Butyl and butynyl benzyl amine compounds |
| 08/03/2010 | CA2526228C Quinoline derivatives as phosphodiesterase inhibitors |
| 08/03/2010 | CA2523081C Macrolide-conjugates with anti-inflammatory activity |
| 08/03/2010 | CA2425165C A process for the preparation of bis-benzazolyl compounds |
| 08/03/2010 | CA2204748C Use of dioxomorpholines for combating endoparasites, new dioxomorpholines and processes for their preparation |
| 07/29/2010 | WO2010085684A1 Compositions and methods for inhibition of the jak pathway |
| 07/29/2010 | WO2010085584A1 Pyrazole-i, 2, 4 -oxad iazole derivatives as s.phing0sine-1-ph0sphate agonists |
| 07/29/2010 | WO2010085582A1 Substituted oxadiazole derivatives as s1p agonists in the treatment of autoimmune and inflammatory diseases |
| 07/29/2010 | WO2010085581A1 Substituted oxadiazole derivatives as s1p agonists in the treatment of autoimmune and inflammatory diseases |
| 07/29/2010 | WO2010084979A1 Benzodiazepin-2-on derivatives |
| 07/29/2010 | WO2010084514A2 A process for the preparation of (5s)-(n)-[[3-[3-fluoro-4-(4-morpholinyl) phenyl]-2-oxo-5-oxazolidinyl] methyl] acetamide |
| 07/29/2010 | WO2010084512A1 Novel oxime derivatives |
| 07/29/2010 | WO2010084152A1 Novel bicyclic antibiotics |
| 07/29/2010 | WO2010084067A2 Insecticidal compounds |
| 07/29/2010 | WO2010065579A3 Fungicidal heterocyclic compounds |
| 07/29/2010 | WO2009158467A3 Di-substituted phenyl compounds as phosphodiesterase 10 inhibitors |
| 07/29/2010 | WO2009158257A4 Fungicidal pyridines |
| 07/29/2010 | WO2009035159A8 3-methyl-2- ( (2s) -2- (4- (3-methyl-1, 2, 4-oxadiazol-5-yl) phenyl) morpholino) -6- (pyrimidin-4-yl) pyrimidin-4 (3h) -one as tau protein kinase inhibitor |
| 07/29/2010 | US20100192240 Regulation of expression of pi3kbeta protein in tumors |
| 07/29/2010 | US20100190979 Diacylglycerol acyltransferase inhibitors |
| 07/29/2010 | US20100190977 4-phenylamino-quinazolin-6-yl-amides |
| 07/29/2010 | US20100190828 Thiazolyl oxime ethers and hydrazones as crop protection agents |
| 07/29/2010 | US20100190822 Pharmaceutical Compositions As Inhibitors of Dipeptidyl Peptidase-IV (DPP-IV) |
| 07/29/2010 | US20100190790 Sigma receptor inhibitors |
| 07/29/2010 | US20100190789 Piperidine/piperazine derivatives |
| 07/29/2010 | US20100190788 Amide derivatives as kinase inhitors |
| 07/29/2010 | US20100190787 Modulators of Mitotic Kinases |
| 07/29/2010 | US20100190785 Method for the purification of mycophenolate mofetil |
| 07/29/2010 | US20100190784 Organic Compounds |
| 07/29/2010 | US20100190783 Triazolone derivatives |
| 07/29/2010 | US20100190780 Sigma receptor inhibitors |
| 07/29/2010 | US20100190779 Viral polymerase inhibitors |
| 07/29/2010 | US20100190777 Compounds and methods for kinase modulation, and indications therefor |
| 07/29/2010 | US20100190770 Compositions and methods for inhibition of the jak pathway |
| 07/29/2010 | US20100190769 Thiazolopyrimidines and their use as inhibitors of phosphatidylinositol-3 kinase |
| 07/29/2010 | US20100190768 Novel fused pyrole derivative |
| 07/29/2010 | US20100190766 Antibacterial agents |
| 07/29/2010 | US20100190762 Triazolyl phenyl benzenesulfonamides |
| 07/29/2010 | US20100190761 Diphenyl substituted alkanes |
| 07/29/2010 | US20100190749 Benzoxazole kinase inhibitors and methods of use |
| 07/29/2010 | US20100190747 Fused ring compound and use thereof |
| 07/29/2010 | US20100190745 Heterocyclic urea derivatives and methods of use thereof |
| 07/29/2010 | CA2750047A1 Novel bicyclic antibiotics |
| 07/29/2010 | CA2749700A1 Benzodiazepin-2-on derivatives |
| 07/29/2010 | CA2749217A1 Compositions and methods for inhibition of the jak pathway |
| 07/28/2010 | EP2210892A2 Neurologically-active compounds |
| 07/28/2010 | EP2210890A1 Oxadiazole derivatives as S1P1 receptor agonists |
| 07/28/2010 | EP2210876A1 Heterocyclic compound |
| 07/28/2010 | EP2210607A1 N-[3-fluoro-4-({6-(methyloxy)-7-[(3-piperidin-1-ylpropyl)oxy]quinolin-4-yl}oxy)phenyl]-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide for the treatment of cancer |
| 07/28/2010 | EP2209776A1 Aminoacyl prodrugs as an active pharmaceutical ingredient for thromboembolic disorder |
| 07/28/2010 | EP2209761A1 Diphenyl substituted cycloalkanes |
| 07/28/2010 | EP2209379A2 Production of monatin enantiomers |
| 07/28/2010 | EP2086939B1 Pyridine carboxamides as 11-beta-hsd1 inhibitors |
| 07/28/2010 | EP1763511B1 Phenoxyacetic acid derivatives as ppar agonists |
| 07/28/2010 | EP1633746B1 New indole derivatives as factor xa inhibitors |
| 07/28/2010 | EP1458392B9 Acridones as inhibitors of impdh enzyme |
| 07/28/2010 | CN1974596B 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors |
| 07/28/2010 | CN1788000B Phthalazinone derivatives |
| 07/28/2010 | CN101790528A aminoacyl prodrugs |
| 07/28/2010 | CN101790526A 5-heteroaryl substituted indazoles as kinase inhibitors |
| 07/28/2010 | CN101790516A Novel substituted piperidones as hsp inducers |
| 07/28/2010 | CN101790514A 1-oxo-isoindoline-4-carboxamide and 1-oxo-1,2,3,4-tetrahydroisoquinoline-5-carboxamide derivatives, preparation and therapeutic use thereof |
| 07/28/2010 | CN101790513A 1,3-dihydroisoindole derivatives |
| 07/28/2010 | CN101787019A Quinazoline derivatives |
| 07/28/2010 | CN101786996A Amino acid and pesticide coupling compound as well as preparation method and application thereof as pesticide |
| 07/28/2010 | CN101786992A 2-hydroxymethyl-3,5,6-trimethylpyrazine derivatives, preparation methods and application thereof |
| 07/27/2010 | US7763627 2-pyridin-4-ylquinazolin-4- amine's such as N-cyclohexyl-2-pyridin-4-ylquinazolin-4- amine, used as tyrosine kinase inhibitors, for modulating cellular activities such as proliferation, differentiation, apoptosis, migration and chemoinvasion; antiproliferative agents and angiogenesis inhibitors |
| 07/27/2010 | US7763613 Substituted N-arylsulfonylheterocyclic amines as gamma-secretase inhibitors |
| 07/27/2010 | US7763612 such as 2S,3S,5R)-4-[5-(aminosulfonyl)-4-chloro-2-[(2-furanylmethyl)amino]benzoyloxymethoxycarbonyl]-2-(3,5-difluorophenyl)-3,5-dimethyl-2-morpholinol, used as anticonvulsants and for the treatment of psychological, nervous system and/or metabolic disorders |
| 07/27/2010 | US7763611 Aroylsemicarbazide derivatives against thromboembolic diseases |
| 07/27/2010 | US7763610 cysteinyl leukotriene antagonists such as 4-(3-carboxypropyl)-8-((4-(4-phenylbutoxy)benzoyl)amino)-3,4-dihydro-2H-1,4-benzoxazine-2-carboxylic acid, used for treating asthma, chronic obstructive pulmonary disease, pneumonia, rhinitis and as expectorants or antitussives |
| 07/27/2010 | US7763236 administering a formulation in the form of a toothpaste, mouthwash, mouth spray or chewing gum, comprising osteopontin effective to inhibit plaque bacterial growth on teeth enamel |
| 07/27/2010 | CA2595815C Salt form of a dopamine agonist |
| 07/27/2010 | CA2437587C Substituted 2-oxo-3-phenyl-5-carbonylaminomethyl-1,3-oxazolines and their use as anticoagulant and antithrombotic agents |
| 07/22/2010 | WO2010083220A1 Benzoxazole inhibitors of poly(adp-ribose)polymerase |
| 07/22/2010 | WO2010083207A2 Protein kinase c inhibitors and uses thereof |
| 07/22/2010 | WO2010082601A1 Novel 2,5-disubstituted pyrrole derivative |
| 07/22/2010 | WO2010082563A1 Cyclic compound having hetero atom |
| 07/22/2010 | WO2010081755A1 Novel herbicides |
| 07/22/2010 | WO2010081692A1 Oxadiazole derivatives as slpl receptor agonists |
| 07/22/2010 | WO2010081387A1 N-substituted phenyl-3-methylene heterocyclic aryl-2,5-dimethylpyrrole compounds and anti-hiv/aids uses thereof |
| 07/22/2010 | WO2010011853A3 Beta-and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds |
| 07/22/2010 | WO2010009029A3 Methods for the preparation of azole compounds |
| 07/22/2010 | WO2010007046A3 Heteroaryl derivatives as dgat1 inhibitors |
| 07/22/2010 | US20100184998 Organic compounds |
| 07/22/2010 | US20100184975 Compounds for alzheimber's disease |
| 07/22/2010 | US20100184809 Heterocyclic FXR Binding Compounds |
| 07/22/2010 | US20100184788 Heterocyclic derivatives |
| 07/22/2010 | US20100184781 Fxa inhibitors with cyclic amidines as p4 subunit, processes for their preparations, and pharmaceutical compositions and derivatives thereof |
| 07/22/2010 | US20100184772 Sulfonamide substituted pyrazoline compounds, their preparation and use as cb1 modulators |
| 07/22/2010 | US20100184767 Substituted oxazolidinones and use thereof |
| 07/22/2010 | US20100184766 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
| 07/22/2010 | US20100184765 Protein Kinase Inhibitors and Methods for Using Thereof |
| 07/22/2010 | US20100184764 Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 07/22/2010 | US20100184763 Quinolone based compounds exhibiting, prolyl hydroxylase inhibitory activity, and compositions, and uses thereof |
| 07/22/2010 | US20100184762 Phthalimide derivatives that influence cellular vesicular systems, pharmaceutical compositions, and use thereof |
| 07/22/2010 | US20100184761 6-PHENYL-1H-IMIDAZO[4,5-c]PYRIDINE-4-CARBONITRILE DERIVATIVES |
| 07/22/2010 | US20100184760 Benzoxazole kinase inhibitors and methods of use |